Skip to main content

Table 1 Laboratory and clinical characteristics of newly diagnosed active MPO-AAV patients and healthy control before treatment

From: Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis

  Active MPO-AAV HC
n 143 176
Age (Y), mean (range) 60 (52–86) 53 (40–75)
Gender (F/M) 69/74 90/86
MPO-ANCA titer, (median, range) 94.97 (18.37–167.98) -
White blood cells (109/l) (mean, SD) 8.70±3.57 6.05±1.11
Neutrophil (109/l) (mean, SD) 6.81±3.36 3.49±0.83
Neutrophil percentage (%) (mean, SD) 76.22±9.46 57.14±7.40
Lymphocyte (109/l) (mean, SD) 1.10±0.54 2.01±0.45
Lymphocyte percentage (%) (mean, SD) 14.09±7.39 33.46±5.74